Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Stimcell Energetics ( (STME) ) has shared an update.
On March 18, 2025, StimCell Energetics Inc. entered into a digital marketing services agreement with Rain Communications Inc. to enhance awareness of its eBalance® product and securities over an eight-month term. Additionally, StimCell settled $15,000 in debt by issuing 75,000 shares of common stock and announced a redesigned, consumer-oriented version of its eBalance® microcurrent therapy device, emphasizing its commitment to user-friendly wellness technology. These strategic moves aim to strengthen StimCell’s financial stability and market presence, potentially benefiting stakeholders by increasing visibility and improving the company’s balance sheet.
More about Stimcell Energetics
StimCell Energetics Inc. is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications such as aging, insulin sensitivity, high blood pressure, neuropathy, and kidney function. The company’s main focus is on the continued research and development of its eBalance® Technology and its eBalance® Home System.
YTD Price Performance: -48.98%
Average Trading Volume: 10,472
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.96M
For detailed information about STME stock, go to TipRanks’ Stock Analysis page.